TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -10.0% | 767 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | 0.0% | 767 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | -41.2% | 767 | -40.5% | 0.00% | -40.0% |
| Q4 2021 | $17,000 | -19.0% | 1,288 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $21,000 | 0.0% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $21,000 | -8.7% | 1,288 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $23,000 | 0.0% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $23,000 | +4.5% | 1,288 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $22,000 | -4.3% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $23,000 | +21.1% | 1,288 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $19,000 | -24.0% | 1,288 | 0.0% | 0.01% | -12.5% |
| Q4 2019 | $25,000 | +13.6% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $22,000 | 0.0% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $22,000 | -15.4% | 1,288 | 0.0% | 0.01% | -11.1% |
| Q1 2019 | $26,000 | – | 1,288 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |